NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis By Ogkologos - November 18, 2025 230 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from MyRisk study Source RELATED ARTICLESMORE FROM AUTHOR Anito-cel, a d-Domain BCMA CAR T-Cell, Induces Rapid, Deep, and Durable Responses in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma EMA Recommends Granting a Marketing Authorisation for Relacorilant Annual Multicancer Early Detection Test Not Associated with a Lower Incidence Rate of Stage III or IV Cancer After Three Screening Rounds and 12... MOST POPULAR Could Functional Precision Medicine Be the New Precision Oncology? August 6, 2026 FDA Approves Tebentafusp-tebn for Unresectable or Metastatic Uveal Melanoma February 7, 2022 EMA Recommends Extension of Indications for Avelumab December 17, 2020 FDA Updates Safety Labelling for Capecitabine and 5-FU on Risks Associated... February 18, 2026 Load more HOT NEWS FDA Grants Accelerated Approval to fam-Trastuzumab Deruxtecan-nxki for HER2-Mutated NSCLC 40 K9 Officers Line Up Outside Terminally Ill Girl’s House For... Adjuvant Everolimus Does Not Improve Recurrence-Free Survival Among Patients with Renal... Sodium Thiosulfate Approved to Reduce Chemo-Related Hearing Loss in Children with...
